studi
approv
anim
care
use
committe
univers
iowa
use
differ
promot
cytokeratin
surfact
protein
c
direct
express
epithelia
figur
supplementari
figur
flag
complementari
dna
origen
clone
vector
creat
human
surfact
protein
c
spc
promot
gift
dr
teodora
georgieva
institut
tucson
arizona
use
gener
vector
purifi
dna
fragment
vector
inject
pronuclei
fertil
x
sjlj
mous
egg
gener
transgen
embryo
mice
transgen
express
detect
polymeras
chain
reaction
pcr
use
follow
primer
forward
cca
aag
act
gta
cgg
gtt
cc
revers
cca
aag
ctg
aat
tgt
ctt
cca
g
merscov
strain
passag
provid
dr
bart
haagman
ron
fouchier
erasmu
medic
center
viru
propag
titer
plaqu
assay
cell
mice
express
anesthet
ketaminexylazin
infect
intranas
merscov
dulbecco
modifi
eagl
medium
dmem
mice
examin
daili
temperatur
weight
record
nontransgen
litterm
serv
control
merscov
work
conduct
biosafeti
level
laboratori
tissu
remov
asept
disassoci
manual
homogen
pb
briefli
centrifug
supernat
remov
sampl
titer
cell
report
elsewher
protein
abund
measur
enzymelink
immunosorb
assay
elisa
human
duoset
catalog
r
system
minneapoli
minnesota
follow
manufactur
protocol
detail
avail
supplementari
materi
detail
avail
supplementari
materi
human
neuroblastoma
cell
line
sknsh
grown
roswel
park
memori
institut
medium
fetal
bovin
serum
fb
glioma
cell
line
murin
astrocytoma
cell
line
dbt
cultur
dmem
fb
primari
porcin
glial
cell
cultur
previous
describ
dissoci
cell
allow
attach
collagenco
plate
cultur
week
cell
infect
merscov
multipl
infect
moi
time
day
infect
supernat
harvest
titer
cell
process
immunostain
venezuelan
equin
enceph
replicon
particl
vrp
express
merscov
glycoprotein
green
fluoresc
protein
gfp
construct
previous
describ
cytokeratin
transgen
mice
immun
foot
pad
infecti
unit
iu
vrp
vrpgfp
pb
boost
dose
week
later
two
week
second
immun
mice
receiv
plaqueform
unit
pfu
merscov
passiv
immun
nontransgen
mice
receiv
iu
vrp
vrpgfp
boost
dose
week
later
two
week
later
serum
harvest
serum
transfer
mice
intraperiton
day
merscov
infect
student
test
analysi
varianc
dunn
multipl
comparison
test
use
analyz
differ
mean
valu
group
unless
otherwis
specifi
result
express
mean
standard
error
standard
deviat
indic
p
valu
consid
statist
signific
broadli
express
human
tissu
cell
primari
cell
cultur
organ
cultur
model
merscov
predominantli
infect
noncili
epitheli
cell
type
respiratori
tract
direct
merscov
receptor
express
pulmonari
epithelia
use
spc
promot
supplementari
figur
promot
figur
describ
method
spc
promot
drive
express
bronchiolar
alveolar
epithelia
contrast
promot
confer
transgen
express
airway
alveolar
epitheli
cell
well
epithelia
liver
kidney
gastrointestin
tract
cell
nervou
system
gener
founder
line
founder
line
first
screen
mice
founder
line
evid
pulmonari
infect
follow
intranas
inocul
pfu
merscov
identifi
line
supplementari
figur
line
figur
product
merscov
infect
base
titer
day
infect
titer
achiev
line
exceed
line
select
founder
line
line
addit
studi
show
highest
viru
titer
day
infect
intranas
infect
transgen
mice
nontransgen
litterm
line
merscov
caus
mortal
chang
bodi
temperatur
mice
fail
gain
weight
compar
nontransgen
litterm
supplementari
figur
data
viru
clear
day
infect
detect
protein
express
brain
heart
lung
kidney
spleen
intestin
liver
mice
figur
contrast
transgen
mice
mice
inocul
intranas
merscov
uniformli
exhibit
weight
loss
hypothermia
die
day
infect
figur
merscov
titer
highest
lung
tissu
day
infect
pfug
tissu
declin
day
infect
contrast
viru
titer
brain
undetect
day
infect
increas
pfug
tissu
day
infect
respect
figur
although
promot
activ
epithelia
multipl
organ
viru
titer
kidney
figur
quantifi
viru
rna
distribut
tissu
blood
pcr
day
infect
figur
viru
rna
abund
lung
day
infect
rna
detect
brain
tissu
day
infect
lower
level
viral
rna
also
detect
spleen
day
infect
kidney
heart
day
infect
also
ask
whether
mice
could
spread
viru
anim
merscov
transmit
infect
mice
n
uninfect
mice
n
hous
cage
data
shown
viru
rna
detect
brain
lung
blood
healthi
cohous
mice
data
shown
surpris
howev
sinc
mice
cough
sneez
merscov
infect
lung
evalu
score
day
infect
tabl
merscov
infect
produc
patchi
consolid
figur
variabl
compos
cellular
inflamm
vascular
congest
atelectasi
airway
gener
intact
scatter
uncommon
slough
cell
figur
lung
lymphat
vessel
fill
degen
cell
cellular
debri
figur
thrombi
figur
also
observ
nearbi
vascular
congest
lesser
hemorrhag
necrosi
alveolar
edema
detect
lung
field
figur
investig
viru
antigen
express
lung
day
infect
supplementari
figur
merscov
nucleocapsid
n
protein
abund
lung
parenchyma
alveolar
type
ii
cell
macrophag
merscov
detect
high
level
infect
mice
transgen
express
brain
corrobor
elisa
figur
evalu
patholog
chang
brain
mice
day
infect
tabl
compar
control
figur
mice
exhibit
perivascular
cuf
figur
cellular
degener
debri
figur
absent
day
progress
chang
day
tabl
degener
die
neuron
sometim
basophil
cytoplasm
inclus
quit
promin
figur
immunostain
viral
antigen
figur
neuron
lesion
sever
thalamu
brain
stem
tabl
moredetail
viru
antigen
stain
brain
tissu
day
infect
shown
supplementari
figur
n
protein
stain
rare
day
infect
princip
seen
solitari
neuron
contrast
day
infect
mani
neuron
infect
viru
antigen
day
infect
preferenti
locat
midbrain
thalamu
deep
cerebr
cortex
region
hippocampu
uncommon
cerebellum
collect
result
show
lung
brain
develop
patholog
chang
merscov
infect
differenti
import
brain
versu
lung
infect
use
low
inoculum
dose
optim
likelihood
brain
lung
would
infect
use
intranas
inocula
pfuanim
compar
mice
receiv
larger
inoculum
onset
weight
loss
delay
day
infect
day
infect
figur
despit
delay
onset
diseas
sign
mice
die
receipt
pfu
inoculum
mice
die
receipt
pfu
inoculum
mice
die
follow
receipt
pfu
inoculum
second
experi
merscov
detect
brain
tissu
mice
infect
pfu
approxim
pfug
tissu
day
infect
viru
titer
lung
tissu
figur
thu
mortal
correl
brain
infect
suggest
infect
organ
import
high
mortal
observ
mice
clinic
cours
mer
sever
ill
patient
sometim
includ
neurolog
manifest
suggest
merscov
may
infect
human
central
nervou
system
note
express
vascular
endothelia
brain
cell
type
determin
whether
merscov
could
infect
complet
replic
cycl
central
nervou
cell
infect
central
nervou
human
cell
line
primari
astrocyt
deriv
newborn
pig
brain
tissu
pig
cell
previous
shown
permiss
merscov
infect
human
cell
line
mg
sknsh
primari
porcin
astrocyt
express
protein
data
shown
sknsh
cell
porcin
astrocyt
control
cell
support
viru
replic
figur
result
confirm
immunostain
merscov
antigen
supplementari
figur
human
autopsi
sampl
avail
directli
assess
viru
replic
brain
result
support
notion
neurolog
diseas
directli
viru
induc
base
studi
cell
infect
vitro
dysregul
cytokin
chemokin
product
postul
contribut
diseas
sever
profil
express
sever
cytokin
chemokin
antivir
gene
product
lung
brain
tissu
day
infect
use
realtim
qpcr
shown
supplementari
figur
observ
overal
trend
host
defens
gene
product
first
induc
lung
follow
later
increas
signal
brain
lung
signific
increas
type
ii
iii
interferon
day
infect
induct
interferon
lung
especi
remark
upregul
class
interferon
occur
later
brain
tissu
reach
level
lung
except
interferon
sever
gene
product
increas
earli
lung
includ
interleukin
interleukin
interleukin
peak
express
rigi
pkr
tumor
necrosi
factor
interleukin
greater
brain
lung
later
time
point
renal
failur
commonli
seen
patient
mer
known
whether
kidney
infect
viru
mice
scatteredtopatchi
evid
tubular
injuri
includ
tubular
dilat
cell
sloughingdebri
cellular
necrosi
supplementari
figur
chang
princip
seen
late
cours
infect
day
infect
case
otherwis
seen
rarelyfoc
day
infect
case
detect
day
infect
case
consist
publish
result
viru
detect
kidney
anim
day
infect
patholog
chang
consist
shock
hypoxia
determin
whether
mice
use
evalu
antimerscov
vaccin
therapi
vaccin
mice
vrp
express
merscov
surfac
glycoprotein
vrp
vrpgfp
prior
merscov
infect
follow
primari
secondari
immun
mice
challeng
pfu
merscov
intranas
shown
figur
immun
mice
complet
protect
lethal
infect
mice
immun
vrp
show
surviv
weight
loss
experi
next
anim
pretreat
serum
mice
immun
vrp
vrpgfp
intraperiton
administr
serum
mice
immun
vrp
day
prior
merscov
infect
complet
prevent
lethal
diseas
manifest
mice
includ
weight
loss
clinic
diseas
figur
control
antigfp
mice
die
also
assess
tissu
titer
mice
follow
passiv
immun
day
infect
observ
acceler
reduct
lung
tissu
titer
immun
mice
viru
titer
day
infect
figur
passiv
immun
complet
prevent
spread
infect
brain
figur
recent
outbreak
south
korea
demonstr
merscov
continu
pose
signific
risk
human
health
report
new
mous
model
merscov
infect
restrict
infect
mous
cell
merscov
level
receptor
gener
mice
express
human
control
spc
promot
challeng
merscov
fatal
diseas
cours
ensu
mice
inflammatori
diseas
involv
lung
brain
tissu
set
sever
diseas
immun
vrp
express
merscov
glycoprotein
confer
protect
immun
mice
exhibit
milder
diseas
phenotyp
transgen
mice
provid
new
model
investig
merscov
infect
evalu
therapeut
intervent
sever
anim
speci
test
suscept
merscov
respiratori
infect
diseas
mice
syrian
hamster
ferret
support
merscov
replic
contrast
rhesu
macaqu
marmoset
rabbit
camel
allow
viru
complet
replic
cycl
marmoset
develop
signific
lung
patholog
associ
mortal
given
larg
inoculum
other
report
minim
diseas
marmoset
phenotyp
mammal
studi
mild
recapitul
sever
merslik
diseas
zhao
et
al
report
first
mous
model
mer
infect
sensit
mice
merscov
infect
deliv
adenoviru
vector
express
lung
mice
howev
lung
express
viru
replic
organ
could
evalu
agraw
et
al
express
behind
univers
express
promot
expand
avail
mous
model
stabli
express
spc
promot
promot
exhibit
morerestrict
express
cagg
promot
use
agraw
et
al
diseas
phenotyp
mice
share
mani
featur
result
report
agraw
et
al
includ
fatal
diseas
lung
brain
involv
contrast
line
demonstr
lower
lung
tissu
viral
load
mice
without
spread
organ
associ
mortal
suggest
infect
restrict
lung
mous
innat
immun
may
success
overcom
virul
factor
express
merscov
prevent
lethal
outcom
mouseadapt
merscov
strain
may
help
overcom
limit
transgen
mice
develop
sever
diseas
featur
interest
analysi
lung
day
infect
reveal
ongo
viru
replic
signific
parenchym
involv
addit
airway
exhibit
rare
slough
cell
cell
debri
observ
within
lymphat
vessel
chang
associ
increas
level
sever
innat
immun
molecul
cytokin
includ
type
ii
iii
interferon
interleukin
interleukin
interleukin
interestingli
level
interferon
predomin
mucos
interferon
lung
markedli
induc
lung
mice
lung
diseas
featur
provid
sever
quantit
end
point
evalu
efficaci
antivir
therapi
previous
use
promot
gener
mice
transgen
human
model
sever
acut
respiratori
syndrom
sar
infect
follow
infect
urbani
strain
sarscov
mice
develop
lethal
diseas
featur
lung
brain
involv
sarscov
spread
olfactori
bulb
primari
secondari
moredist
connect
rapidli
result
lethal
present
studi
tempor
cours
brain
tissu
infect
also
suggest
retrograd
viru
spread
olfactori
neuron
suscept
brain
infect
set
high
bar
evalu
new
therapi
merscov
infect
demonstr
util
model
vaccin
test
acknowledg
hightit
replic
death
central
nervou
system
diseas
transgen
mice
may
complic
studi
vaccin
therapeut
intervent
especi
drug
cross
bloodbrain
barrier
mice
develop
lethal
diseas
enceph
contribut
demis
brain
infect
mous
model
mer
relev
diseas
human
note
express
brain
human
mammal
found
merscov
infect
human
nervou
cell
line
primari
porcin
astrocyt
possibl
merscov
gain
access
human
central
nervou
system
disrupt
blood
brain
barrier
via
lymphat
rout
cell
express
could
support
viru
replic
current
knowledg
limit
absenc
publish
postmortem
data
person
die
mer
interestingli
arabi
et
al
recent
describ
patient
mer
sever
neurolog
manifest
includ
alter
conscious
diffus
brain
abnorm
magnet
reson
imag
involv
white
matter
subcort
area
frontal
tempor
pariet
lobe
basal
ganglia
corpu
callosum
mani
reason
sever
ill
patient
mer
might
manifest
neurolog
sign
symptom
report
indic
mer
associ
progress
neurolog
manifest
data
need
understand
whether
patient
mer
central
nervou
system
involv
infect
summari
mer
mous
model
provid
resourc
investig
earli
diseas
mechan
therapeut
intervent
provid
econom
altern
avail
model
merscov
infect
